Peptoid-based antimicrobial strategies against polymyxin-resistant Gram-negative bacteria

Key Points

• The aim is to evaluate TM8 as a potential antimicrobial candidate targeting polymyxin-resistant bacteria.
• Evaluation of antimicrobial efficacy of TM8 against polymyxin-resistant bacteria.
• Recommendations for further studies on safety and pharmacokinetics of TM8.
• TM8 shows promise as an antimicrobial agent against resistant strains.
• Further studies are needed to assess safety profiles and detailed pharmacological properties.

Abstract